June 1, 2020
Via: ReutersAs drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking to secure manufacturing capacity under its “Operation Warp Speed” program announced in May to accelerate vaccine development. “Securing more manufacturing capacity here in […]
Industry Focus Areas, Medical, Regulations
May 19, 2020
Via: Reuters(Reuters) – The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times reported late […]
July 9, 2024
June 25, 2024
Copyright © 2024. All rights reserved
